a5 subunit-containing GABA A (a5GABA A ) receptors that generate a low amplitude tonic inhibitory conductance in the hippocampus. 14 Inhaled anaesthetics, including isoflurane and sevoflurane, potently and effectively increase a5GABA A receptor function, 15 an effect that might contribute to the acute memory blocking properties of these drugs. 16 17 Intense enhancement of a5GABA A receptors might also trigger longterm post-anaesthetic memory loss that persists 24-48 h after the anaesthetic has been eliminated. We previously showed that genetic and pharmacologic interventions, that reduce a5GABA A receptor function during acute exposure to isoflurane prevent post-anaesthetic memory deficits that otherwise can last for days. 18 -20 Specifically, null-mutant mice lacking a5GABA A receptors (Gabra52/2) were resistant to long-term memory deficits produced by sevoflurane and isoflurane, suggesting that a5GABA A receptors are necessary for post-anaesthetic memory deficits. 18 19 Further, treatment of animals during exposure to isoflurane with an imidazobenzodiazepine inverse agonist that is selective for a5GABA A receptors, L-655,708 (FG-8094, C 18 H 19 N 3 O 4 ), prevented memory deficits. 20 These results suggest that inverse agonists can attenuate the potentiating effect of anaesthetics at a5GABA A receptors. Inverse agonists act as negative allosteric modulators of a5GABA A receptors by binding to the benzodiazepine site and decreasing receptor function. 21 Studies of recombinantly expressed GABA A receptors showed that the dissociation constant of L-655,708 for a5GABA A receptors is 50-to 100-fold lower than for GABA A receptors containing a1, a2, a3, or a6 subunits. 20 The half-maximal inhibitory concentration of L-655,708 for a5GABA A receptors is 1.1 nM, a value that is considerably lower than for GABA A receptors containing the a1 (320 nM), a2 (135 nM), and a3 (960 nM) subunits. 22 Another inverse agonist, MRK-016 (C 17 H 20 N 8 O 2 ), which is structurally distinct from L-655,708, also preferentially inhibits a5GABA A receptors and improves memory performance. 23 24 The aim of this in vitro study was to determine whether L-655,708 and MRK-016 inhibited sevoflurane-and isofluranemediated enhancement of GABA A receptor activity. We also sought to determine whether reversal of anaestheticmediated potentiation was specific for a5GABA A receptors.
Methods

Cell culture
The experiments were approved by the Animal Care Committee of the University of Toronto (Protocol number: 20009455). Gabra52/2 mice were generated using a C57BL/6J and Sv129Ev background, as previously described. 25 Swiss white mice (timed pregnant mice from Charles River, Toronto, ON, Canada), were also used for some experiments because the number of wild-type and Gabra52/2 mice available was limited. Hippocampal neuronal cultures were prepared as previously described. 14 Briefly, fetal pups (embryonic day 18) were removed from mice that had been killed by cervical dislocation. The fetal hippocampus was collected, and neurones were dissociated by mechanical titration, plated at a density of 10 6 cells ml 21 4 with NaOH and to 320-330 mOsm with water or glucose). Tetrodotoxin (TTX, 300 nM) was added to the extracellular solution to block voltage-gated sodium channels, and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 mM) and 2-amino-4-phosphonovaleric acid (D-AP5, 40 mM) were added to inhibit the ionotropic glutamate receptors. The extracellular solution was applied to neurones by a computer-controlled, multibarrelled perfusion system (SF-77B, Warner Instruments, Hamden, CT, USA). Currents were analysed with the pClamp 10 software (Molecular Devices). Current amplitude was normalized by cell capacitance to determine current density (pA pF 21 ). 27 28 To construct the concentration-response plot for sevoflurane, currents were normalized (I/I max ), where I is the current amplitude and I max is the largest current recorded in the experiment. The concentration -response plot was fitted to the modified Michaelis -Menten equation:
, where c is the concentration of sevoflurane, EC 50 is the concentration of sevoflurane that produces currents with 50% of maximal amplitude, and nH is the estimated Hill coefficient.
Drugs and chemicals
Sevoflurane and isoflurane were obtained from Abbott Laboratories (North Chicago, IL, USA). CNQX and D-AP5 were obtained from Sigma-Aldrich (Oakville, ON, Canada). Tetrodotoxin was purchased from Alomone Labs (Jerusalem, Israel). L-655,708 and MRK-016 were obtained from Tocris Bioscience (Bristol, UK). Anaesthetic solutions were diluted from saturated aqueous phase of sevoflurane (11.8 mM) 29 and isoflurane (2.5 mM) 29 prepared at room temperature (20 -238C), as previously described. 30 For the generation of the concentration -response curve, a range of sevoflurane concentrations were studied. For all other experiments concentrations equivalent to the minimal alveolar concentration (MAC) of sevoflurane 31 and isoflurane 15 29 were used. Stock solutions of all other reagents were prepared with distilled water.
Statistical analysis
Differences between groups were determined using a Student's t-test or a one-way analysis of variance (ANOVA) with a Dunnett multiple-comparison post hoc test. P,0.05 was considered significant. GraphPad Prism 5 (GraphPad Software, Inc., CA, USA) was used to generate the bar charts.
Results are presented as mean (SEM).
Results
L-655,708 selectively inhibits a5GABA A receptors
As a5GABA A receptors are preferentially activated by low GABA concentrations, 32 we first studied whether currents evoked by low compared with high concentrations of GABA exhibit a greater sensitivity to L-655,708. The peak amplitude of current evoked by GABA (0. , P,0.01, n¼5 or 6, Fig. 1B] . When the concentration of GABA was further increased, L-655,708 had no effect (n¼5 or 6, Fig. 1C and D) . Collectively, the results show that L-655,708 effectively inhibits currents evoked by low but not high concentrations of GABA.
We next sought to determine whether the selectivity of L-655,708 is specific for a5GABA A receptors. GABA (0.5 mM)-evoked currents were smaller in Gabra52/2 neurones compared with wild-type neurones, as shown previously 50 500 GABA Fig 1 L-655 ,708 inhibits currents evoked by low, but not high, concentrations of GABA in neurones from Swiss white mice. Summarized data show that L-655,708 (L6) has a concentration-dependent inhibitory effect on currents evoked by GABA (0.1 and 1 mM) but no effect on currents evoked by GABA (10 and 100 mM) (n¼5-6). **P,0.01 vs GABA. Data are mean (SEM).
P¼0.024, n¼6, Fig. 2A while a lower concentration of L-655,708 (5 nM) had no significant effect (n¼6, Fig. 2A and C) . In Gabra52/2 neurones, L-655,708 had no effect on GABA (0. 200% of control, Gabra52/2: 180% of control). As predicted, co-application of L-655,708 had no effect on sevofluranemediated potentiation in Gabra52/2 neurones (n¼6, Fig. 3B and D). Collectively, these results indicate that L-655,708 attenuates sevoflurane potentiation of GABA-evoked current in a concentration-dependent manner in wild-type but not Gabra52/2 neurones, and that the sevoflurane potentiation of current is smaller in Gabra52/2 neurones. Next, the effects of L-655,708 on sevoflurane concentration-response plots were studied (Fig. 4) . Co-application of L-655,708 (50 nM) with sevoflurane (2 and 3 mM) caused a significant inhibition of sevoflurane potentiation [34 (9) % and 20 (6) %, respectively, P,0.05, n¼6]. On the other hand, co-application of L-655,708 with higher sevoflurane concentrations (6 and 8 mM) had no effect. L-655,708 shifted the sevoflurane concentration-response plot to the right without affecting the maximal response (Fig. 4B) . The EC 50 was increased from 1.9 (0.1) mM to 2.4 (0.2) mM (P,0.05, n¼6) in the absence and presence of L-655,708, respectively. These results demonstrate that L-655,708 reduced the potency of sevoflurane, but had no effect on its efficacy at high concentrations.
L-655,708 attenuates isoflurane-induced potentiation of GABA-evoked currents
To determine whether the inhibitory effect of inverse agonists on anaesthetic-induced potentiation could be generalized to different volatile anaesthetics, the effect of L-655,708 on isoflurane potentiation of GABA-evoked currents was studied. For these studies, hippocampal neurones from Swiss white mice were used. L-655,708 caused a concentration-dependent decrease in the GABA (0. 
MRK-016 attenuates sevoflurane-and isoflurane-induced potentiation of GABA-evoked currents
We next studied the effects of MRK-016 to determine whether other inverse agonists also reduce anaesthetic enhancement of the GABA A receptor activity. MRK-016 caused a concentration-dependent decrease in GABA current 
Discussion
This study provides the first evidence that inverse agonists attenuate the potentiation of GABA A receptor activity by inhaled general anaesthetics. L-655,708 and MRK-016 caused a concentration-dependent reduction in the effects of both sevoflurane and isoflurane on GABA-evoked current in mouse hippocampal neurones. The decrease in sevoflurane enhancement of GABA-evoked current by L-655,708 was dependent on the expression of a5GABA A receptors, as this effect was only observed in wild-type neurones but not Gabra52/2 neurones. The concentration of L-655,708 is a key determinant of its selectivity for a5GABA A receptors. In addition, GABA-evoked whole-cell currents in hippocampal neurones are generated by heterogeneous populations of GABA A receptors with different subunit compositions and different affinities for GABA. 13 32 Thus, the effects of several L-655,708 concentrations (5-500 nM) on currents evoked by a range of GABA concentrations (0.1-100 mM) were studied. L-655,708 reduced current evoked by low (0.1 and 1 mM) but not high (10 and 100 mM) concentrations of GABA, consistent with the relative selectivity of L-655,708 for high-affinity GABA A receptors. 13 Notably, the lowest concentration of L-655,708 (5 nM) was insufficient to inhibit GABA-evoked currents. This result contrasts with previous studies done in recombinant human GABA A receptors that showed a half-maximal inhibitory concentration of 1.1 nM for L-655,708. 22 Nevertheless, L-655,708
(50 and 500 nM) appears to inhibit current primarily generated by a5GABA A receptors because the inhibitory effects of L-655,708 were absent in neurones from Gabra52/2 mice. These results suggest that the potency of L-655,708 could be lower for native GABA A receptors or that the low concentrations of GABA activated a heterogeneous population of GABA A receptors in the cultured neurones. The mechanisms underlying the interaction(s) between inverse agonists and volatile anaesthetics on the GABA A receptor complex are unknown but likely result from reciprocal allosteric coupling between the benzodiazepine binding site and the anaesthetic modulatory domain. 33 L-655,708 exerts its inhibitory effect by acting on a specific benzodiazepine binding site of GABA A receptors. 20 Electrophysiological experiments showed that positive agonists of the benzodiazepine site, such as diazepam, allosterically increase the opening frequency of the GABA A receptors and thereby increase chloride influx and shunting inhibition. 34 35 As L-655,708 acts on the same binding site as benzodiazepines, L-655,708 might also reduce frequency of channel opening. 16 In contrast, volatile anaesthetics act at binding cavities that are distinct from the benzodiazepine site. 36 37 Positive benzodiazepine modulators such as midazolam can synergistically interact with anaesthetics to enhance GABA A receptor function. 38 39 Our results demonstrate that inverse agonists exert the opposite effect to positive benzodiazepine allosteric modulators possibly via reciprocal allosteric coupling.
A growing body of evidence implicates a5GABA A receptors in triggering anaesthetic-induced memory deficits that persist after the drugs have been eliminated. 18 19 These receptors are highly expressed in hippocampus 8 where they primarily mediate persistent, tonic inhibition. 9 Under physiological conditions, a5GABA A receptors play a pivotal role in learning and memory processes, 14 as genetic deletion or pharmacological inhibition of a5GABA A receptors can improve memory performance. 40 41 Increasing the function of these receptors reduces neuronal excitability, decreases the firing of action potentials, 25 reduces synaptic plasticity in the hippocampus, and can cause memory deficits. 42 The specific molecular mechanisms by which anaestheticinduced enhancement of a5GABA A receptor function can induce long-term memory deficits are unknown and are a topic for future studies. However, our results support the intriguing notion that L-655,708 and related agents might be useful for preventing memory deficits after anaesthesia.
